Cell therapy company developing allogeneic off-the-shelf products for patients with high unmet medical need At Catamaran our mission is to harness.

Catamaran bio inc. Catamaran Bio is developing treatments for cancer based on natural killer cells in the immune system. CAMBRIDGE Mass-- BUSINESS WIRE--Catamaran Bio announces appointment of Dr. Our proprietary capabilities enable us to harness the natural cancer-fighting properties of NK cells and enhance and tailor their effectiveness with the power of synthetic biology and innovative non-viral cell engineering.

Preclinical studies confirm that the biological features we are engineering into our CAR-NK cell therapies result in profound effects against solid tumors as well as hematologic malignancies. Alvin Shih as President and Chief Executive Officer. Subscribe to Catamaran Bio.

Free and open company data on Massachusetts US company CATAMARAN BIO INC. April 26 2021 Catamaran Bio Inc a biotechnology company developing allogeneic CAR-NK cell therapies to treat patients with significant unmet medical need today announced the appointment of Scott Holmes MS MBA as Chief Financial OfficerMr. Office 300 Technology Square 8th Floor Cambridge MA 02139.

CAMBRIDGE MassCatamaran Bio Inc a biotechnology company developing allogeneic CAR-NK cell therapies to treat diseases with significant unmet medical need announced the appointment of Alvin Shih MD MBA as President and Chief Executive Officer. Technical scientific consultation or product development for others in the fields of biotechnology cell therapy and development of pharmaceuticals and. Catamaran Bio Announces Appointment of Dr.

Catamaran Bio Inc a biotechnology company developing allogeneic CAR-NK cell therapies to treat diseases with significant unmet medical need today announced the appointment of Alvin Shih MD MBA as President and Chief Executive OfficerHe has concurrently been appointed to the Board of Directors for Catamaran. Vipin Suri PhD MBA Chief Scientific Officer who has more than 20 years of biopharmaceutical experience including as a co-founder of Obsidian Therapeutics and Serien formerly Raze Therapeutics and earlier in R. Alvin Shih as President and Chief Executive Officer.

Labs Lab Central 700 Main Street Cambridge MA 02139. Vedere Bio ll Inc. CATAMARAN trademark registration is intended to cover the categories of pharmaceutical research and development.